01163-7/asset/f29611d8-43e0-475b-8d92-bab260b93b12/main.assets/gr2_lrg.jpg)
cagrilintide clinical trial Efficacy and safety of co-administered once-weekly 2·4 mg with once-weekly semaglutide 2·4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 Cagrilintide 5mg: complete dosing, reconstitution,
Description
doi:10.1080/10408398.2021.1896473
For people on higher dose protocols, the 10mg protocol and the considerations around higher unit doses are relevant, since higher doses tend to produce stronger side effect profiles, particularly in the first 24 to 48 hours post-injection
Beyond the first 12 weeks, EllieMD provides a check-in and reassessment every 3 months to evaluate your progress and determine if any adjustments are needed
Final assessments quantify total gains
The suggested frequency may rise to two-three times per week for weight loss and fat metabolism
